Insulin action and insulin resistance in human skeletal muscle

Diabetologia

Volumn 43, Issue 7, 2000, Pages 821-835

  Zierath, J R ^a   Krook, A ^b   Wallberg Henriksson, H ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Exercise; Glucose transport; Hyperglycaemia; Insulin signalling; Obesity

Indexed keywords

EXERCISE; GLUCOSE TRANSPORT; HORMONE ACTION; HUMAN; HYPERGLYCEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; MUSCLE CONTRACTION; MUSCLE METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SKELETAL MUSCLE;

EID: 0033942001     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250051457     Document Type: Review

References (173)

1. Shepherd PR, Kahn BB (1999) Glucose transporters and insulin action. N Engl J Med 341: 248-257
2. Wallberg-Henriksson H, Holloszy JO (1985) Activation of glucose transport in diabetic muscle: Responses to contraction and insulin. Am J Physiol 249: C233-C237
3. Zierath JR (1995) In vitro studies of human skeletal muscle. Hormonal and metabolic regulation of glucose transport. Acta Physiol Scand 155: 1-96
4. Manson JE, Spelsberg A (1995) Reduction in risk factors of coronary heart disease and diabetes. In: Ruderman N, Devlin J (eds) The Health Professionals Guide to Diabetes and Exercise. The American Diabetes Association, Alexandria, p 51-58
5. Arner P, Pollare T, Lithell H (1991) Different aetiologies of Type II (non-insulin-dependent) diabetes mellitus in obese and nonobese subjects. Diabetologia 34: 483-487
6. Kelley DE, Mokan M, Mandarino LJ (1993) Metabolic pathways of glucose in skeletal muscle of lean NIDDM patients. Diabetes Care 16: 1158-1166
7. DeFronzo RA (1988) The Triumvirate: β-cell, muscle or liver. A collusion responsible for NIDDM. Diabetes 37: 667-687
8. DeFronzo RA, Jocot E, Jequier E, Maeder E, Wahren J, Felber JP (1981) The effect of insulin on the disposal of intravenous glucose. Diabetes 30: 1000-1007
9. DeFronzo RA, Gunnarsson R, Björkman O, Olsson M, Wahren J (1985) Effects of insulin on peripheral and splanchnic glucose metabolism in non-insulin-dependent (Type II) diabetes mellitus. J Clin Invest 76: 149-155
10. DeFronzo RA, Tobin JD, Anders R (1979) Glucose clamp technique: a model for quantifying insulin secretion and resistance. Am J Physiol 237: E214-E223
11. Nuutila P, Koivisto VA, Knuuti J et al. (1992) Glucose-free fatty acid cycle operates in human heart and skeletal muscle in vivo. J Clin Invest 89: 1767-1774
12. Eriksson J, Koranyi L, Bourey R et al. (1992) Insulin resistance in Type II (non-insulin-dependent) diabetic patients and their relatives is not associated with a defect in the expression of the insulin-responsive glucose transporter (GLUT4) gene in human skeletal muscle. Diabetologia 35: 143-147
13. Shulman GI, Rothman DL, Jue T, Stein P, DeFronzo RA, Shulman RG (1990) Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy. N Engl J Med 322: 223-228
14. Henriksen JE, Alford F, Handberg A et al. (1994) Increased glucose effectiveness in normoglycemic but insulin-resistant relatives of patients with non-insulin-dependent diabetes mellitus. J Clin Invest 94: 1196-1204
15. Groop L, Bonadonna RC, Del Prato S et al. (1989) Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus: Evidence for multiple sites of insulin resistance. J Clin Invest 84: 205-213
16. Bonadonna RC, Del Prato S, Bonora E et al. (1996) Roles of glucose transport and glucose phosphorylation in muscle insulin resistance of NIDDM. Diabetes 45: 915-925
17. Kahn CR (1994) Insulin action, diabetogenes, and the cause of Type II diabetes. Diabetes 43: 1066-1084
18. White MF, Kahn CR (1994) The insulin signaling system. J Biol Chem 269: 1-4
19. Virkamäki A, Ueki K, Kahn CR (1999) Protein-protein interactions in insulin signaling and the molecular mechanisms of insulin resistance. J Clin Invest 103: 931-943
20. Araki E, Lipes MA, Patti ME et al. (1994) Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene. Nature 372: 186-190
21. Whithers DJ, Gutierrez JS, Towery H et al. (1998) Disruption of IRS-2 causes type 2 diabetes in mice. Nature 391: 900-904
22. White MF (1998) The insulin signalling system: a network of docking protein that mediate insulin action. Mol Cell Biochem 182: 3-11
23. Yeh J-I, Gulve EA, Rameh L, Birnbaum MJ (1995) The effects of wortmannin on rat skeletal muscle. J Biol Chem 270: 2107-2111
24. Lund S, Holman GD, Schmitz O, Pedersen O (1995) Contraction stimulates translocation of glucose transporter GLUT4 in skeletal muscle through a mechanism distinct from that of insulin. Proc Natl Acad Sci USA 92: 5817-5821
25. Lee AD, Hansen PA, Holloszy JO (1995) Wortmannin inhibits insulin-stimulated but not contraction-stimulated glucose transport activity in skeletal muscle. FEBS Lett 361: 51-54
26. Inoue G, Cheatham B, Emkey R, Kahn CR (1998) Dynamics of insulin signaling in 3T3-L1 adipocytes. Differential compartmentalization and trafficking of insulin receptor substrate (IRS)-1 and IRS-2. J Biol Chem 273: 11548-11555
27. Clark SF, Martin S, Carozzi AJ, Hill MM, James DE (1998) Intracellular localization of phosphatidylinositide 3-kinase and insulin receptor substrate-1 in adipocytes: potential involvement of a membrane skeleton. J Cell Biol 140: 1211-1225
28. Inukai K, Anai M, Van Breda E et al. (1996) A novel 55-kDa regulatory subunit for phosphatidylinositol 3-kinase structurally similar to p55PIK is generated by alternative splicing of the p85α gene. J Biol Chem 271: 5317-5320
29. Inukai K, Funaki M, Ogihara T et al. (1997) p85α gene generates three isoforms of regulatory subunit for phosphatidylinositol 3-kinase (PI 3-kinase) p50α, p55α, and p85α, with different response to insulin. J Biol Chem 272: 7873-7882
30. Anai M, Funaki M, Ogihara T et al. (1998) Altered expression levels and impaired steps in the pathway to phosphatidylinosital 3-kinase activation via insulin receptor substrates 1 and 2 in Zucker Fatty rats. Diabetes 47: 13-23
31. Shepherd PR, Navé B, Rincon J et al. (1997) Differential regulation of phosphoinositide 3-kinase adapter subunit variants by insulin in human skeletal muscle. J Biol Chem 272: 19000-19007
32. Kohn AD, Kovacina KS, Roth RA (1995) Insulin stimulates the kinase activity of RAC-PK, a pleckstrin homology domain containing ser/thr kinase. EMBO J 14: 4288-4295
33. Burgering BMT, Coffer PJ (1995) Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature 376: 599-602
34. phox by a membrane-targeted phosphoinositide 3-kinase. Curr Biol 6: 1271-1278
35. Kohn AD, Summers SA, Birnbaum MJ, Roth RA (1996) Expression of a constitutively active Akt Ser/Thr kinase in 3T3-L1 adipocytes stimulates glucose uptake and glucose transporter 4 translocation. J Biol Chem 271: 31372-31378
36. Tanti J-F, Grillo S, Grémeaux T, Coffer PJ, Van Obberghen E, Le Marchand-Brustel Y (1997) Potential role of protein kinase B n glucose transporter 4 translocation in adipocytes. Endocrinology 138: 2005-2010
37. Hajduch E, Alessi DR, Hemmings BA, Hundal HS (1998) Constitutive activation of protein kinase Bα by membrane targeting promotes glucose and system A amino acid transport, protein synthesis, and inactivation of glycogen synthase kinase 3 in L6 muscle cells. Diabetes 47: 1006-1013
38. Ueki K, Yamamoto-Honda R, Kaburagi Y et al. (1998) Potential role of protein kinase B in insulin-induced glucose transport, glycogen synthesis, and protein synthesis. J Biol Chem 273: 5315-5322
39. Wang Q, Somwar R, Bilan PJ et al. (1999) Protein kinase B/Akt participates in GLUT4 translocation by insulin in L6 myoblasts. Mol Cell Biol 19: 4008-4018
40. Kitamura T, Ogawa W, Sakaue H et al. (1998) Requirement for activation of the serine-threonine kinase Akt (Protein kinase B) in insulin stimulation of protein synthesis but not glucose transport. Mol Cell Biol 18: 3708-3717
41. Nishizuka Y (1995) Protein kinase C and lipid signaling for sustained cellular responses. FASEB J 9: 484-496
42. Dekker LV, Parker PJ (1994) Protein kinase-C: a question of specificity. Trends Biochem Sci 19: 73-77
43. Hug H, Sarre TF (1993) Protein kinase C isoenzymes: divergence in signal transduction? Biochem J 291: 329-343
44. Hansen PA, Corbett JA, Holloszy JO (1997) Phorbol esters stimulate muscle glucose transport by a mechanism distinct from the insulin and hypoxia pathways. Am J Physiol 273: E28-E36
45. Standaert ML, Galloway L, Karnam P, Bandyopadhyay G, Moscat J, Farese RV (1997) Protein kinase C- as a downstream effector of phosphatidylinositol 3-kinase during insulin stimulation in rat adipocytes. Potential role in glucose transport. J Biol Chem 272: 30075-30082
46. Nakanishi H, Brewer KA, Exton JH (1993) Activation of the ζ isoenzyme of protein kinase C by phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem 268: 13-16
47. Kotani K, Ogawa W, Matsumoto M et al. (1998) Requirement of atypical protein kinase C λ for insulin stimulation of glucose uptake but not for Akt activation in 3T3-L1 adipocytes. Mol Cell Biol 18: 6971-6982
48. Bandyopadhyay G, Standaert ML, Zhao L et al. (1997) Activation of protein kinase C (α, β, and ζ) by insulin in 3T3/L1 cells: Transfection studies suggest a role for PKC-ζ in glucose transport. J Biol Chem 272: 2551-2558
49. Hirshman MF, Goodyear LJ, Wardzala LJ, Horton ED, Horton ES (1990) Identification of an intracellular pool of glucose transporters from basal and insulin-stimulated rat skeletal muscle. J Biol Chem 265: 987-991
50. Ploug T, van Deurs B, Ai H, Cushman SW, Ralston E (1998) Analysis of GLUT4 distribution in whole skeletal muscle fibers: identification of distinct storage compartments that are reduced by insulin and muscle contractions. J Cell Biol 142: 1429-1446
51. Gumà A, Zierath JR, Wallberg-Henriksson H, Klip A (1995) Insulin induces translocation of GLUT-4 glucose transporters in human skeletal muscle. Am J Physiol 268: E613-E622
52. James DE, Strube MM, Mueckler MM (1989) Molecular cloning and characterization of an insulin-regulatable glucose transporter. Nature 338: 83-87
53. Charron MJ, Brosius FC, Alper SL, Lodish HL (1989) A glucose transport protein expressed predominately in insulin-sensitive tissues. Proc Natl Acad Sci USA 86: 2535-2539
54. Birnbaum MJ (1989) Identification of a novel gene encoding an insulin-responsive glucose transporter protein. Cell 57: 305-315
55. Ren JM, Marshall BA, Gulve EA et al. (1993) Evidence from transgenic mice that glucose transport is rate limiting for glycogen deposition and glycolysis in skeletal muscle. J Biol Chem 268: 16113-26115
56. Treadway JL, Hargrave MD, Nardone NA et al. (1994) Enhances peripheral glucose utilization in transgenic mice expressing the human GLUT4 gene. J Biol Chem 269: 29956-29961
57. Marshall BA, Mueckler MM (1994) Differential effects of GLUT1 or GLUT4 overexpression on insulin responsiveness in transgenic mice. Am J Physiol 267: E738-E744
58. Holman GD, Kasuga M (1997) From receptor to transporter: Insulin signalling to glucose transport. Diabetologia 40: 991-1003
59. Dohm GL, Tapscott EB, Pories WJ et al. (1988) An in vitro human skeletal muscle preparation suitable for metabolic studies. Decreased insulin stimulation of glucose transport in muscle from morbidly obese and diabetic subjects. J Clin Invest 82: 486-494
60. Andréasson K, Galuska D, Thörne A, Sonnenfeld T, Wallberg-Henriksson H (1991) Decreased insulin-stimulated 3-O-methylglucose transport in in vitro incubated muscle strips from type II diabetic subjects. Acta Physiol Scand 142: 255-260
61. 3H in frog muscle. J Biol Chem 238: 40-49
62. Zierath JR, Houseknecht K, Gnudi L, Kahn BB (1997) High fat feeding impairs insulin-stimulated GLUT4 recruitment in muscle via an early insulin signaling defect. Diabetes 46: 215-223
63. Wallberg-Henriksson H (1986) Insulin treatment normalizes decreased glucose transport capacity in streptozotocin-diabetic rats. Acta Physiol Scand 128: 647-659
64. Heydrick SJ, Gautier N, Olichon-Berthe C, Van Obberghen E, Le Marchand-Brustel Y (1995) Early alteration of insulin stimulation of PI 3-kinase in muscle and adipocyte from gold thioglucose obese mice. Am J Physiol 268: E604-E612
65. Kraegen EW, James DE, Storlien LH, Burleigh KM, Crisholm DJ (1986) In vivo insulin resistance in individual peripheral tissues of the high fat fed rat: assessment by euglycaemic clamp plus deoxyglucose administration. Diabetologia 29: 192-198
66. Wallberg-Henriksson H, Zetan N, Henriksson J (1987) Reversibility of decreased insulin-stimulated glucose transport capacity in diabetic muscle with in vitro incubation. J Biol Chem 262: 7665-7671
67. Krook A, Kawano Y, Song XM et al. (1997) Improved glucose tolerance restores insulin-stimulated Akt kinase activity and glucose transport in skeletal muscle from diabetic Goto-Kakizaki (GK) rats. Diabetes 46: 2110-2114
68. Song XM, Kawano Y, Krook A et al. (1999) Muscle fiber- type specific defects in insulin signal transduction to glucose transport in diabetic Goto-Kakizaki rats. Diabetes 48: 664-670
69. Heydrick SJ, Jullien D, Gautier N et al. (1993) Defect in skeletal muscle phosphatidylinositol-3-kinase in obese insulin-resistant mice. J Clin Invest 91: 1358-1366
70. Galuska D, Nolte L, Zierath JR, Wallberg-Henriksson H (1994) Effect of metformin on glucose transport in isolated skeletal muscle obtained from Type II diabetic patients and healthy individuals. Diabetologia 37: 872-879
71. Krook A, Roth RA, Jiang XJ, Zierath JR, Wallberg-Henriksson H (1998) Insulin-stimulated Akt kinase activity is reduced in skeletal muscle from non-insulin-dependent diabetic subjects. Diabetes 47: 1281-1286
72. Cline GW, Petersen KF, Krssak M et al. (1999) Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes. N Engl J Med 341: 240-246
73. Zierath JR, Galuska D, Nolte L, Thörne A, Smedegaard-Kristensen J, Wallberg-Henriksson H (1994) Effects of glycemia on glucose transport in isolated skeletal muscle from patients with NIDDM: in vitro reversal of muscular insulin resistance. Diabetologia 37: 270-277
74. Strömmer L, Permert J, Arnelo U et al. (1998) Skeletal muscle insulin resistance after surgical trauma: insulin signaling and glucose transport. Am J Physiol 275: E351-E358
75. Lund S, Holman GD, Zierath JR et al. (1997) Effect of insulin on GLUT4 translocation and turnover rate in human skeletal muscle as measured by the exofacial bismannose photolabeling technique. Diabetes 46: 1965-1969
76. Holman GD, Kozka IJ, Clark AE et al. (1990) Cell-surface labeling of glucose transporter isoform GLUT4 by Bis-Mannose photolabel: correlation with stimulation of glucose transport in rat adipose cells by insulin and phorbol ester. J Biol Chem 265: 18172-18179
77. Björnholm M, Kawano Y, Lehtihet M, Zierath JR (1997) Insulin receptor substrate-1 phosphorylation and phosphatidylinositol 3-kinase activity are decreased in skeletal muscle from NIDDM subjects following in vivo insulin stimulation. Diabetes 46: 524-527
78. Goodyear LJ, Giorgino F, Sherman LA, Carey J, Smith RJ, Dohm GL (1995) Insulin receptor phosphorylation, insulin receptor substrate-1 phosphorylation and phosphatidylinositol 3-kinase activity are decreased in intact skeletal muscle strips from obese subjects. J Clin Invest 95: 2195-2204
79. Nolan JJ, Freidenberg G, Henery R, Reichart D, Olefsky JM (1994) Role of human skeletal muscle insulin receptor kinase in the in vivo insulin resistance of noninsulin-dependent diabetes mellitus and obesity. J Clin Endocrinol Metab 78: 471-477
80. Nyombia BL, Ossowski VM, Bogardus C, Mott DM (1990) Insulin-sensitive tyrosine kinase relationship with in vivo insulin action in humans. Am J Physiol 258: E964-E974
81. Krook A, Björnholm M, Galuska D et al. (2000) Characterization of signal transduction and glucose transport in skeletal muscle from type 2 diabetic patients. Diabetes 49: 284-292
82. Garvey WT, Maianu L, Zhu JH, Brechtel-Hook G, Wallace P, Baron AD (1998) Evidence for defects in the trafficking and translocation of GLUT4 glucose transporters in skeletal muscle as a cause of human insulin resistance. J Clin Invest 101: 2377-2386
83. Vogt B, Muhlbacher C, Carrascosa J et al. (1992) Subcellular distribution of GLUT 4 in the skeletal muscle of lean Type II (non-insulin-dependent) diabetic patients in the basal state. Diabetologia 35: 456-463
84. Folli F, Saad MJA, Backer JM, Kahn CR (1993) Regulation of phosphatidylinositol 3-kinase activity in liver and muscle of animal models of insulin-resistant and insulin-deficient diabetes mellitus. J Clin Invest 92: 1787-1794
85. Saad MJA, Folli F, Kahn JA, Kahn CR (1993) Modulation of insulin receptor, insulin receptor substrate-1, and phosphatidylinositol 3-kinase in liver and muscle of dexamethasone-treated rats. J Clin Invest 92: 2065-2072
86. Saad MJA, Araki E, Miralpeix M, Rothenberg PL, White MF, Kahn CR (1992) Regulation of insulin receptor substrate-1 in liver and muscle of animal models of insulin resistance. J Clin Invest 90: 1839-1849
87. Maegawa H, Shigeta Y, Egawa K, Kobayashi M (1991) Impaired autophosphorylation of insulin receptors from abdominal skeletal muscles in nonobese subjects with NIDDM. Diabetes 40: 815-819
88. Klein HH, Vestergaard H, Kotzke G, Pedersen O (1995) Elevation of serum insulin concentration during euglycemic hyperinsulinemic clamp studies leads to similar activation of insulin receptor kinase in skeletal muscle of subjects with and without NIDDM. Diabetes 44: 1310-1317
89. Zierath JR, Krook A, Wallberg-Henriksson H (1998) Insulin action in insulin resistant skeletal muscle from NIDDM subjects. Mol Cell Biochem 182: 153-160
90. Arner P, Pollare T, Lithell H, Livingston JN (1987) Defective insulin receptor tyrosine kinase in human skeletal muscle in obesity and Type II (non-insulin-dependent) diabetes mellitus. Diabetologia 30: 437-440
91. Kim YB, Nikoulina SE, Ciaraldi TP, Henry RR, Kahn BB (1999) Normal insulin-dependent activation of Akt/protein kinase B, with diminished activation of phosphoinositide 3-kinase, in muscle in type 2 diabetes. J Clin Invest 104: 733-741
92. Zierath JR, He L, Guma A, Wahlström E, Klip A, Wallberg-Henriksson H (1996) Insulin action on glucose transport and plasma membrane GLUT4 content in skeletal muscle from patients with NIDDM. Diabetologia 39: 1180-1189
93. Franke TF, Yang SI, Chan TO et al. (1995) The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase. Cell 81: 727-736
94. Alessi DR, James SR, Downes CP et al. (1997) Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Bα. Curr Biol 7: 261-269
95. Shepherd PR, Nave BT, Rincon J et al. (1997) Involvement of phosphoinositide 3-kinase in insulin stimulation of MAP-kinase and phosphorylation of protein kinase-B in human skeletal muscle: implications for glucose metabolism. Diabetologia 40: 1172-1177
96. Ruderman NB, Saha AK, Vavvas D, Witters LA (1999) Malonyl-CoA, fuel sensing, and insulin resistance. Am J Physiol 276: E1-E18
97. Schmitz-Peiffer C, Browne CL, Oakes ND et al. (1997) Alterations in the expression and cellular localization of protein kinase C isozymes epsilon and theta are associated with insulin resistance in skeletal muscle of the high- fat-fed rat. Diabetes 46: 169-178
98. Avignon A, Yamada K, Zhou X et al. (1996) Chronic activation of protein kinase C in soleus muscles and other tissues of insulin-resistant type II diabetic Goto-Kakizaki (GK), obese/aged, and obese/Zucker rats. A mechanism for inhibiting glycogen synthase. Diabetes 45: 1396-1404
99. Kawano Y, Rincon J, Soler A et al. (1999) Hyperglycemia-induced changes in glucose transport and protein kinase Cβ2 in rat skeletal muscle. Diabetologia 42: 1071-1079
100. Pillay TS, Xiao S, Olefsky JM (1996) Glucose-induced phosphorylation on the insulin receptor. J Clin Invest 97: 613-620
101. Griffin ME, Marcucci MJ, Cline GW et al. (1999) Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade. Diabetes 48: 1270-1274
102. Nagy K, Levy J, Grunberger G (1991) Impaired translocation of protein kinase C activity in human non-insulin-dependent diabetes mellitus. Metabolism 40: 807-813
103. Considine RV, Nyce MR, Allen LE et al. (1995) Protein kinase C is increased in the liver of humans and rats with non-insulin-dependent diabetes mellitus: an alteration not due to hyperglycemia. J Clin Invest 95: 2938-2944
104. Dohm G, Elton C, Friedman J et al. (1991) Decreased expression of glucose transporters in muscle from insulin-resistant patients. Am J Physiol 260: E459-E463
105. Handberg A, Vaag A, Damsbo P, Beck-Nielsen H, Vinten J (1990) Expression of insulin-regulatable glucose transporters in skeletal muscle from Type II (non-insulin-dependent) diabetic patients. Diabetologia 33: 625-627
106. Pedersen O, Bak JF, Andersen PH et al. (1990) Evidence against altered expression of GLUT1 or GLUT4 in skeletal muscle of patients with obesity or NIDDM. Diabetes 39: 865-870
107. Jullien D, Tanti J-F, Heydrick S et al. (1993) Differential effects of okadaic acid on insulin-stimulated glucose and amino acid uptake and phosphatidylinositol 3-kinase activity. J Biol Chem 268: 15246-15251
108. Kahn BB, Schulman GI, DeFronzo RA, Cushman SW, Rossetti L (1991) Normalization of blood glucose in diabetic rats with phlorizin treatment reverses insulin-resistant glucose transport in adipose cells without restoring glucose transporter gene expression. J Clin Invest 87: 561-570
109. Rossetti L, Smith D, Schulman GI, Papachristou D, De Fronzo RA (1987) Correction of hyperglycemia with phlorizin normalizes tissue sensitivity to insulin in diabetic rats. J Clin Invest 79: 1510-1515
110. Rossetti L, Hawkins M, Chen W, Gindi J, Barzilai N (1997) In vivo glucosamine infusion induces insulin resistance in normoglycemic but not hyperglycemic conscious rats. J Clin Invest 96: 132-140
111. Henry RR, Wallace P, Olefsky JM (1986) Effects of weight loss on mechanisms of hyperglycemia in obese non-insulin-dependent diabetes mellitus. Diabetes 35: 990-998
112. Friedman JE, Dohm GL, Leggett-Frazier N et al. (1992) Restoration of insulin responsiveness in skeletal muscle of morbidly obese patients after weight loss. J Clin Invest 89: 701-705
113. Kolterman OG, Gray RS, Shapiro G, Scarlett JA, Griffin J, Olefsky JM (1984) The acute and chronic effects of sulfonylurea therapy in type II diabetic subjects. Diabetes 33: 346-354
114. Greenfield H, Doberne L, Rosenthal M, Schulz B, Widstrom A, Reaven GM (1982) Effect of sulfonylurea treatment on in vivo insulin secretion and action in patients with non-insulin-dependent diabetes mellitus. Diabetes 31: 307-312
115. Ginsberg H, Rayfield EJ (1981) Effect of insulin therapy on insulin resistance in type II diabetic subjects. Evidence for heterogeneity. Diabetes 30: 739-745
116. Garvey WT, Olefsky JM, Griffin J, Hamman RF, Kolterman OG (1985) The effect of insulin treatment on insulin secretion and insulin action in type II diabetes mellitus. Diabetes 34: 222-234
117. Yki-Järvinen H, Helve E, Koivisto V (1987) Hyperglycemia decreases glucose uptake in type I diabetes. Diabetes 36: 892-896
118. Friedman JE, Ishizuka T, Shao J, Huston L, Highman T, Catalano P (1999) Impaired glucose transport and insulin receptor tyrosine phosphorylation in skeletal muscle from obese women with gestational diabetes. Diabetes 48: 1807-1814
119. Goto Y, Suzuki K-I, Sasaki M, Ono T, Abe S (1988) GK rat as a model of non-obese non-insulin-dependent diabetes: selective breeding over 35 generations. In: Shafrir E, Renold A (eds) Frontiers in Diabetes Research. Lessions from Animal Diabetes. John Libbey, London, pp 301-303
120. Kurowski TG, Lin Y, Luo Z et al. (1999) Hyperglycemia inhibits insulin activation of Akt/protein kinase B, but not phosphatidylinositol 3-kinase in rat skeletal muscle. Diabetes 48: 658-663
121. Wallberg-Henriksson H (1987) Glucose transport in skeletal muscle. Influence of contractile activity, insulin, catecholamines, and diabetes mellitus. Acta Physiol Scand 131: 1-80
122. Richter EA, Garetto LP, Goodman MN, Ruderman NB (1982) Muscle glucose metabolism following exercise in the rat. J Clin Invest 69: 785-793
123. Richter EA, Garetto LP, Goodman MN, Ruderman NB (1984) Enhanced muscle glucose metabolism after exercise: modulation by local factors. Am J Physiol 246: E476-E482
124. Lund S, Flyvbjerg A, Holman GD, Larsen FS, Pedersen O, Schmitz O (1994) Comparative effects of IGF-1 and insulin on the glucose-transporter system in rat muscle. Am J Physiol 267: E461-E466
125. Cartee GD, Douen AG, Ramlal T, Klip A, Holloszy JO (1991) Stimulation of glucose transport in skeletal muscle by hypoxia. J Appl Physiol 70: 1593-1600
126. Zierath JR, Tsao T-S, Stenbit AE, Ryder JW, Galuska D, Charron MJ (1998) Restoration of hypoxia-stimulated glucose uptake in GLUT4-deficient muscles by muscle-specific GLUT4 transgenic complementation. J Biol Chem 273: 20910-20915
127. Vavvas D, Apazidis A, Saha AK et al. (1997) Contraction-induced changes in acetyl-CoA carboxylase and 5′-AMP-activated kinase in skeletal muscle. J Biol Chem 272: 13255-13261
128. Hayashi T, Hirshman MF, Kuth EJ, Winder WW, Goodyear LJ (1998) Evidence for 5′-AMP-activated protein kinase mediation of the effect of muscle contraction on glucose transport. Diabetes 47: 1369-1373
129. Youn JH, Gulve EA, Holloszy JO (1991) Calcium stimulates glucose transport in skeletal muscle by a pathway independent of contraction. Am J Physiol 260: C555-C561
130. Youn JH, Gulve EA, Henriksen EJ, Holloszy JO (1994) Interactions between effects of W-7, insulin, and hypoxia on glucose transport in skeletal muscle. Am J Physiol 267: R888-R894
131. Douen AG, Ramlal T, Rastogi SA et al. (1990) Exercise induces recruitment of the "insulin responsive" glucose transporter. Evidence for distinct intracellular insulin- and exercise-recruitable transporter pools in skeletal muscle. J Biol Chem 265: 13427-13430
132. Wallberg-Henriksson H, Holloszy JO (1984) Contractile activity increases glucose uptake by muscle in severely diabetic rats. J Appl Physiol 57: 1045-1049
133. Wallberg-Henriksson H, Constable SH, Young DA, Holloszy JO (1988) Glucose transport into rat skeletal muscle: interaction between exercise and insulin. J Appl Physiol 65: 909-913
134. Wahren J, Hagenfeldt L, Felig P (1975) Splanchnic and leg exchange of glucose, amino acids, and free fatty acids during exercise in diabetes mellitus. J Clin Invest 55: 1303-1314
135. Hübingen A, Franzen A, Gries FA (1987) Hormonal and metabolic response to physical exercise in hyperinsulinaemic and nonhyperinsulinaemic type 2 diabetics. Diabetes Res Clin Pract 4: 57-61
136. Schneider SH, Vitug A, Ruderman NB (1986) Atherosclerosis and physical activity. Diabetes Metab Rev 1: 514-553
137. Larsen JJ, Dela F, Kjaer M, Galbo H (1997) The effect of moderate exercise on postprandial glucose homeostasis in NIDDM patients. Diabetologia 40: 447-453
138. Minuk HL, Vranic M, Marliss EB, Hanna AK, Albisser AM, Zinman B (1981) Glucoregulatory and metabolic response to exercise in obese noninsulin-dependent diabetes. Am J Physiol 240: E458-E464
139. Burstein R, Epsteinm Y, Shapiro Y, Charuzi I, Karnieli E (1990) Effect of an acute bout of exercise on glucose disposal in human obesity. J Appl Physiol 69: 299-304
140. Kennedy JW, Hirshman MF, Gervino EV et al. (1999) Acute exercise induces GLUT4 translocation in skeletal muscle of normal human subjects and subjects with type 2 diabetes. Diabetes 48: 1192-1197
141. Rodgers MA, Yamamoto C, King DS, Hagberg JM, Ehsani AA, Holloszy JO (1988) Improvement in glucose tolerance after 1 wk of exercise in patients with mild NIDDM. Diabetes Care 11: 613-618
142. Hughes VA, Fiatarone MA, Fielding RA et al. (1993) Exercise increases muscle GLUT4-levels and insulin action in subjects with impaired glucose tolerance. Am J Physiol 264: E855-E862
143. Rodnick KJ, Henriksen EJ, James DE, Holloszy JO (1992) Exercise training, glucose transporters, and glucose transport in rat skeletal muscles. Am J Physiol 262: C9-C14
144. Ploug T, Stallknecht BM, Pedersen O et al. (1900) Effect of endurance training on glucose transport capacity and glucose transporter expression in rat skeletal muscle. Am J Physiol 259: E778-E786
145. Houmard JA, Egan PC, Neufer PD et al. (1991) Elevated skeletal muscle glucose transporter levels in exercise-trained middle-aged men. Am J Physiol 261: E437-E443
146. Houmard JA, Shinebarger MH, Dolan PL et al. (1993) Exercise training increases GLUT-4 protein concentration in previously sedentary middle-aged men. Am J Physiol 264: E896-E901
147. Andersen PH, Lund S, Schmitz O, Junker S, Kahn BB, Pedersen O (1993) Increased insulin-stimulated glucose uptake in athletes: the importance of GLUT4 mRNA, GLUT4 protein and fibre type composition of skeletal muscle. Acta Physiol Scand 149: 393-404
148. Dela F, Handberg A, Mikines KJ, Vinten J, Galbo H (1993) GLUT4 and insulin receptor binding and kinase activity in trained human muscle. J Physiol 469: 615-624
149. Hjeltnes N, Galuska D, Björnholm M et al. (1998) Exercise-induced overexpression of key regulatory proteins involved in glucose uptake and metabolism in tetraplegic persons: molecular mechanism for improved glucose homeostasis. FASEB J 12: 1701-1712
150. Vestergaard H, Bjøjbæk C, Hansen T, Larsen FS, Granner DK, Pedersen P (1995) Impaired activity and gene expression of hexokinase II in muscle from non-insulin-dependent diabetes mellitus patients. J Clin Invest 96: 2639-2645
151. Mandarino LJ, Printz RL, Cusi KA et al. (1995) Regulation of hexokinase II and glycogen synthase mRNA, protein, and activity in human muscle. Am J Physiol 269: E701-E708
152. Bak JF, Pedersen O (1990) Exercise-activation of glycogen synthase in human skeletal muscle. Am J Physiol 258: E957-E963
153. Vestergaard H, Bjorbaek C, Andersen PH, Bak JF, Pedersen O (1991) Impaired expression of glycogen synthase mRNA in skeletal muscle of NIDDM patients. Diabetes 40: 1740-1745
154. Vestergaard H, Lund S, Larsen FS, Bjerrum OJ, Pedersen O (1993) Glycogen synthase and phosphofructokinase protein and mRNA levels in skeletal muscle from insulin-resistant patients with non-insulin-dependent diabetes mellitus. J Clin Invest 91: 2342-2350
155. Goodyear LJ, Chang P-Y, Sherwood DJ, Durfesne SD, Moller DE (1996) Effects of exercise and insulin on mitogen-activated protein kinase signaling pathways in rat skeletal muscle. Am J Physiol 271: E403-E408
156. Aronson D, Violan MA, Dufresne SD, Zangen D, Fielding RA, Goodyear LJ (1997) Exercise stimulates the mitogenic-activated protein kinase pathway in human skeletal muscle. J Clin Invest 99: 1251-1257
157. Aronson D, Dufresne SD, Goodyear LJ (1997) Contractile activity stimulates the c-Jun NH2-terminal kinase pathway in rat skeletal muscle. J Biol Chem 272: 25636-25640
158. Widegren U, Jiang XJ, Krook A et al. (1998) Divergent effects of exercise on metabolic and mitogenic signaling pathways in human skeletal muscle. FASEB J 12: 1379-1389
159. Ryder JW, Fahlman R, Wallberg-Henriksson H, Alessi DR, Krook A, Zierath JR (2000) Effect of contraction on mitogen-activated protein kinase signal transduction in skeletal muscle: involvement of the mitogen- and stress-activated protein kinase 1. J Biol Chem 275: 1457-1462
160. Cohen P (1997) The search for physiological substrates of MAP and SAP kinases in mammalian cells. Trends Cell Biol 7: 353-361
161. Hansen PA, Gulve EA, Marshall BA et al. (1995) Skeletal muscle glucose transport and metabolism are enhanced in transgenic mice overexpressing the GLUT4 glucose transporter. J Biol Chem 270: 1679-1684
162. Ren J-M, Marshall BA, Mueckler MM, McCaleb M, Amatruda JM, Schulman GI (1995) Overexpression of GLUT4 protein in muscle increases basal and insulin-stimulated whole body glucose disposal in conscious mice. J Clin Invest 95: 429-432
163. Tsao T-S, Stenbit A, Li J et al. (1997) Muscle-specific transgenic complementation of GLUT4-deficient mice: preferential effects of glucose but not lipid metabolism. J Clin Invest 100: 671-677
164. Tsao TS, Burcelin R, Katz EB, Huang L, Charron MJ (1996) Enhanced insulin action due to targeted GLUT4 overexpression exclusively in muscle. Diabetes 45: 28-36
165. Ikemoto S, Thompson KS, Takahashi M, Itakura H, Lane MD, Ezaki O (1995) High fat diet-induced hyperglycemia: prevention by low level expression of a glucose transporter (GLUT4) minigene in transgenic mice. Proc Natl Acad Sci USA 92: 3096-3099
166. Leturque A, Loizeau M, Vaulont S, Salminen M, Girard J (1996) Improvement of insulin action in diabetic transgenic mice selectively overexpressing GLUT4 in skeletal muscle. Diabetes 45: 23-27
167. Gibbs EM, Stock JL, McCoid SC et al. (1995) Glycemic improvement in diabetic db/db mice by overexpression of the human insulin-regulatable glucose transporter (GLUT4). J Clin Invest 95: 1512-1518
168. Fink RI, Wallace P, Brechtel G, Olefsky JM (1992) Evidence that glucose transport is rate-limiting for in vivo glucose uptake. Metabolism 41: 867-902
169. Yki-Jarvinen H, Young AA, Lamkin C, Foley JE (1987) Kinetics of glucose disposal in whole body and across the forearm in man. J Clin Invest 79: 1713-1719
170. Chang P-Y, Jensen J, Printz RL, Granner DK, Ivy JI, Moller DE (1996) Overexpression of hexokinase II in transgenic mice. J Biol Chem 271: 14834-14839
171. Dela F, Mikines KJ, von Linstow M, Secher NH, Galbo H (1992) Effect of training on insulin-mediated glucose uptake in human muscle. Am J Physiol 263: E1134-E1143
172. Kim Y, Inoue T, Nakajima R et al. (1995) Effects of endurance training on gene expression of insulin signal transduction pathway. Biochem Biophys Res Commun 210: 766-773
173. Chibalin AV, Yu M, Ryder JW et al. (2000) Exercise-induced changes in expression and activity of proteins involved in insulin signal transduction in skeletal muscle: differential effects on insulin receptor substrates 1 and 2. Proc Natl Acad Sci USA 97: 38-43